glp 1 vs sglt2 weight loss Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain Perspectives in weight control in

One of our friends is actually using them, which gave us some extra confidence

Retrieved March 10, 2026, from 20 Newman, E

Patients in large clinical trials for GLP-1s lost an average of 15% to 20% of their body weight, depending on the drug they were given

5.3 The "Tregs-Microglia-Neuron/NPCs" axis and GLP-1R/cAMP/PKA/IL-10 mediated immunosuppressive and neuroprotective effects of GLP-1RAs in ischemic stroke In summary, in the pathological state of ischemic stroke, T cells preferentially migrated to the lesion boundary, and significantly increased after ischemia, peaking in the following weeks and persisting for several months (71)